The Norwegian University of Science and Technology is a public research university in Norway with the main campus in Trondheim and smaller campuses in Gjøvik and Ålesund. The largest university in Norway, NTNU has over 8,000 employees and over 40,000 students.

During the past decade, Norwegian University of Science and Technology conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norwegian University of Science and Technology" #1 sponsor was "Norwegian University of Science and Technology" with 55 trials, followed by "European LeukemiaNet" with 1 trials sponsored, "Oslo University Hospital" with 1 trials sponsored, "Radboud University Medical Center" with 1 trials sponsored and "Scandinavian Prostate Cancer Group" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norwegian University of Science and Technology" #1 collaborator was "St. Olavs Hospital" with 22 trials as a collaborator, "Norwegian University of Science and Technology" with 5 trials as a collaborator, "SINTEF Health Research" with 3 trials as a collaborator, "Haukeland University Hospital" with 2 trials as a collaborator and "Helse Midt-Norge" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Norwegian University of Science and Technology" are "Obesity" (8 trials), "Needlestick Injuries" (5 trials), "Atrial Fibrillation" (4 trials), "Ageing" (3 trials) and "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "Norwegian University of Science and Technology" in a lesser frequency.

Most popular intervention types in "Norwegian University of Science and Technology" are "Behavioral" (34 trials), "Procedure" (10 trials), "Other" (9 trials), "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control" (4 trials), "Exercise training" (4 trials), "Moderate intensity exercise" (3 trials), "Botulinum Toxin Type A" (2 trials) and "Botulinum Toxin Type A 25 IU" (2 trials). Other intervention names were less common.

The vast majority of trials in "Norwegian University of Science and Technology" are 58 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Norwegian University of Science and Technology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in Norwegian University of Science and Technology, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Norwegian University of Science and Technology, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 41 trials that are defined as “Not Applicable".

Norwegian University of Science and Technology has several departments that took part in Clinical trials: "Department of Psychology, Norwegian University of Science and Technology" - 3 trials, "Department for circulation and medical imaging, NTNU" - 2 trials, "Norwegian University of Science and Technology, Faculty of Medicine" - 2 trials, "Dept Circulation and Medical Imaging, EXCAR Exercise Lab" - 2 trials, "Norwegian University of Science and Technology (NTNU), Faculty of Medicine, Dept. of Neuroscience, Center for Child and Adolescent Mental Health" - 2 trials